The Granules Of Chuanxiong Qingnao Clinical Research About Treatment 57 Patients With Migraine (Wind-damp Disorder,Blood Stasis)

Purpose: Now observe Chuanxiong Qingnao Treated Migraine(wind-damp disorder blood stasis syndrome)clinical efficacy and safety characteristics.Method: Clinical approach to the study of self-control,treatment for two weeks,followed up for 2 months after stopping.Chuanxiong Qingnao particles Ltd.is provided by Ji Chuan Pharmaceutical Group(Zhunzi Z20060177),10 g / bag.Usage: blunt,1 bag / time,3times a day.Observation Chuanxiong Qingnao Treated Migraine(rheumatism blinded,blood stasis syndrome)improving the number of episodes of the patient,the degree of headache onset,clinical symptoms and other aspects of the case.Result: The clinical study included 60 cases,57 cases in line.Of 57 patients with migraine after Chuanxiong Qingnao particles 2 weeks of treatment,headache episodes significantly reduced 2 weeks of treatment were compared with the previous one week of treatment and treatment(P<0.05),headache degree(VAS score)and headache days were lower than pre-treatment levels,and the difference was statistically significant(P<0.05);the average drug evaluation during the onset time of 3.285 hours,in the fifth day of treatment since the onset of the cumulative percentage after taking>50%.Reduce the number of patients taking painkillers,two weeks of treatment in patients taking painkillers often lower than first week of treatment(P = 0.046 <0.05).Clinical symptoms improved significantly,2 weeks of treatment compared with before treatment analysis showed that: improve the TCM differences in patient symptom scores before and after all statistically significant(P<0.05).Total hours before and after clinical symptoms improved significantly(P<0.05).Follow-up period,the overall efficacy in patients with clinical symptoms scale analysis,there are two weeks of treatment efficiency is higher than 1 week of treatment,the difference was statistically significant(P = 0.043 <0.05).Conclusion: Chuanxiong Qingnao particles can significantly reduce the onset of headache patients,reduce the number of migraine attacks,improve clinical symptoms,and no significant adverse reactions,safety,and should be promoted in clinical.